Users Coming Off Slimming Jabs Regain Weight Four Times Faster Than Those on Conventional Diets

A recent study suggests that patients who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt traditional diet and exercise programs.

Findings released in a leading health publication points out that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.

"People using these treatments should be aware of the danger of fast rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb.

Such speed of recovery means a return to pre-treatment mass in about one and a half years.

Analyzing Therapies

The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the results of these new drugs with other pills.

The team note that individuals who shed pounds through lifestyle changes alone typically see a slower creep back—approximately 0.1 kg a month—after stopping.

The Reason for the Quick Regain

Nutrition scientists propose the mode of action of the injections explains the heightened weight return.

These medications copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication leads to appetite is unsuppressed, making overeating much more probable."

A Chronic Disease?

Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals contend that, given the significant potential of weight regain, the therapy is often life-long.

This opinion is supported by pharmaceutical companies, who say that the findings "highlight the chronic character of excess weight," akin to managing diseases like hypertension.

Patient Accounts

Users who have come off the jabs describe a sudden return of appetite.

"I experienced something activating and you become ravenous," said an individual.

This difficulty is worsened if users have not developed lasting lifestyle or habit modifications during therapy.

Significant Use

Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among females than males.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, researchers caution that while these medications are powerful agents for shedding pounds, they are not a standalone fix and long-term success likely depends on combined lifestyle management.